Mesa Laboratories, Inc. (MLAB) fair value analysis
Nasdaq · Updated 2026-09-12
Mesa Laboratories, Inc. is a technology company that specializes in providing products and services for sterilization validation and monitoring, as well as biological and chemical indicators used in healthcare and industrial settings. The company operates globally, serving customers across medical device manufacturing, pharmaceutical, and healthcare industries.
Valuation status
Awaiting full valuationMLAB does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under our standards — we require at least six validated trailing price-to-earnings windows before publishing one. TickrTrends re-evaluates every covered stock weekly; a verdict publishes automatically once enough validated history accumulates.
- Last price
- $125.47
- Sector
- Technology
- 12-month range
- $70.02–$125.47
Derived indicators
Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.
- Quality grade
- B
- Leverage
- Moderate
- Margin trend
- Expanding
- Revenue growth
- Modest
- RSI zone
- Neutral
- 50/200-day trend
- Uptrend
- 52-week position
- The top quarter of its range
- DCF cross-check
- Fairly Valued
What our data shows for MLAB
- Our model validated 1 trailing price-to-earnings windows for MLAB, built from monthly EPS history.
- Shares are trading in the upper third of their 12-month price range of $70.02–$125.47.
- The 14-day relative strength index sits at a neutral 55.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for MLAB
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.
Recent MLAB news
TickrTrends' derived news-sentiment signal for MLAB is currently leaning positive, computed from recent coverage.
- Mesa Laboratories Inc (MLAB) Shares Surge 4.1% -- What GF Score of 75 Tells Investors (gurufocus.com, 2026-09-03)
- Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary (finance.yahoo.com, 2026-08-11)
- Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028 (NASDAQ:MLAB) (seekingalpha.com, 2026-08-11)
What people are saying
Follow the MLAB conversation: Stocktwits · Reddit · X
TickrTrends weekly updates
- 2026-09-12 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.
Frequently asked questions
Is MLAB stock undervalued?
MLAB does not yet have sufficient validated earnings history for a full Forward Fair Value verdict under TickrTrends' standards; it is re-evaluated every week.
What is MLAB's TickrTrends verdict?
MLAB is currently marked 'Awaiting full valuation' - a verdict publishes automatically once at least six validated trailing P/E windows accumulate.
Is MLAB overbought or oversold?
MLAB's 14-day RSI is in neutral territory - neither overbought nor oversold.